Dyne Therapeutics Inc. (DYN) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Dyne Therapeutics Inc.

NASDAQ: DYN · Real-Time Price · USD
13.06
0.51 (4.06%)
At close: Oct 03, 2025, 3:59 PM
13.25
1.45%
After-hours: Oct 03, 2025, 07:11 PM EDT

Dyne Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
435.45M 121.63M 172.15M 200.82M
Short-Term Investments
206.82M 1.47M 83.86M 175.75M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
1.94M 2.31M 11.9M 2.31M
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
17.01M 6.28M 9.58M n/a
Total Current Assets
659.28M 129.38M 265.59M 382.39M
Property-Plant & Equipment
30.01M 33.39M 38.41M 40.96M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
31.95M 35.71M 50.31M 43.27M
Total Assets
691.23M 165.08M 306.32M 425.66M
Account Payables
6.56M 22.94M 5.26M 4.03M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
4.85M n/a 4.61M 3.89M
Other Current Liabilities
26M 12.94M 7.67M 11.81M
Total Current Liabilities
42.26M 51.09M 28.09M 28.72M
Long-Term Debt
n/a 22.7M 25.87M 28.74M
Other Long-Term Liabilities
n/a -22.7M -25.87M -28.74M
Total Long-Term Liabilities
19.14M 22.7M 25.87M 28.74M
Total Liabilities
61.4M 73.79M 53.96M 57.47M
Total Debt
23.99M 27.41M 30.48M 32.64M
Book Value
629.84M 91.29M 252.36M 368.2M
Book Value Per Share
6.69 1.53 4.86 7.23
Common Stock
10K 6K 6K 6K
Retained Earnings
-949.93M -632.51M -396.57M -228.47M
Comprehensive Income
6K n/a -571K -269K
Shareholders Equity
629.84M 91.29M 252.36M 368.2M
Total Investments
206.82M 1.47M 83.86M 175.75M